Page 7 - Ancer Prostate News Today

CtDNA tests have the potential to identify many cancer types but researchers must assess their efficacy across different racial/ethnic groups.

An oncologist was surprised to see that health insurer WellCare denied approval for a drug she had prescribed within the indication. Before she could appeal, WellCare restarted the review process.

A blood clot was misdiagnosed as sciatica, which led to the loss of a leg and a huge malpractice verdict.

Over the past 30 years, survival of patients with de novo metastatic cancers shows divergent trends, with substantial gains against some cancers but limited or no progress against others.

For nearly 30 years, guidelines have recommended halting cervical screening at age 65, despite limited science. A $3 million NIH study is now underway to settle the question of when its safe to stop.

Patients with inflammatory rheumatic diseases often change their diets. A rheumatologist recently reviewed the data about this approach to disease management.

The radioligand treatment Pluvicto is in short supply, which could extend for months, according to its manufacturer Novartis.

A study from the US Department of Defense found cancer incidence was higher among military air and ground crew in comparison with the general population, but they were not more likely to die from cancer.

A urologist and andrologist recently reviewed the situations in which penile rehabilitation is indicated for the prevention of chronic erectile dysfunction.

New findings show that a plant-based diet along with exercise can reduce a patients risk of prostate cancer progressing or recurring.